BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 36703986)

  • 1. Diagnostic challenge in a series of eleven patients with hyper IgE syndromes.
    Yaakoubi R; Mekki N; Ben-Mustapha I; Ben-Khemis L; Bouaziz A; Ben Fraj I; Ammar J; Hamzaoui A; Turki H; Boussofara L; Denguezli M; Haddad S; Ouederni M; Bejaoui M; Chan KW; Lau YL; Mellouli F; Barbouche MR; Ben-Ali M
    Front Immunol; 2022; 13():1057679. PubMed ID: 36703986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The extended clinical phenotype of 64 patients with dedicator of cytokinesis 8 deficiency.
    Engelhardt KR; Gertz ME; Keles S; Schäffer AA; Sigmund EC; Glocker C; Saghafi S; Pourpak Z; Ceja R; Sassi A; Graham LE; Massaad MJ; Mellouli F; Ben-Mustapha I; Khemiri M; Kilic SS; Etzioni A; Freeman AF; Thiel J; Schulze I; Al-Herz W; Metin A; Sanal Ö; Tezcan I; Yeganeh M; Niehues T; Dueckers G; Weinspach S; Patiroglu T; Unal E; Dasouki M; Yilmaz M; Genel F; Aytekin C; Kutukculer N; Somer A; Kilic M; Reisli I; Camcioglu Y; Gennery AR; Cant AJ; Jones A; Gaspar BH; Arkwright PD; Pietrogrande MC; Baz Z; Al-Tamemi S; Lougaris V; Lefranc G; Megarbane A; Boutros J; Galal N; Bejaoui M; Barbouche MR; Geha RS; Chatila TA; Grimbacher B
    J Allergy Clin Immunol; 2015 Aug; 136(2):402-12. PubMed ID: 25724123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Key findings to expedite the diagnosis of hyper-IgE syndromes in infants and young children.
    Hagl B; Heinz V; Schlesinger A; Spielberger BD; Sawalle-Belohradsky J; Senn-Rauh M; Magg T; Boos AC; Hönig M; Schwarz K; Dückers G; von Bernuth H; Pache C; Karitnig-Weiss C; Belohradsky BH; Frank J; Niehues T; Wahn V; Albert MH; Wollenberg A; Jansson AF; Renner ED
    Pediatr Allergy Immunol; 2016 Mar; 27(2):177-84. PubMed ID: 26592211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atopic dermatitis, STAT3- and DOCK8-hyper-IgE syndromes differ in IgE-based sensitization pattern.
    Boos AC; Hagl B; Schlesinger A; Halm BE; Ballenberger N; Pinarci M; Heinz V; Kreilinger D; Spielberger BD; Schimke-Marques LF; Sawalle-Belohradsky J; Belohradsky BH; Przybilla B; Schaub B; Wollenberg A; Renner ED
    Allergy; 2014 Jul; 69(7):943-53. PubMed ID: 24898675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The first cohort of Iranian patients with hyper immunoglobulin E syndrome: A long-term follow-up and genetic analysis.
    Tavassoli M; Abolhassani H; Yazdani R; Ghadami M; Azizi G; Abdolrahim Poor Heravi S; Moeini Shad T; Kokabee M; Movahedi M; Abdshahzadeh H; Gharagozlou M; Rezaei N; Esmaeilzadeh H; Aleyasin S; Aghamohammadi A
    Pediatr Allergy Immunol; 2019 Jun; 30(4):469-478. PubMed ID: 30801830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyper IgE syndromes: clinical and molecular characteristics.
    Al-Shaikhly T; Ochs HD
    Immunol Cell Biol; 2019 Apr; 97(4):368-379. PubMed ID: 30264496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hyper-IgE syndromes].
    He YY; Liu B; Xiao XP
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 31(11):892-896. PubMed ID: 29775011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dedicator of cytokinesis 8 regulates signal transducer and activator of transcription 3 activation and promotes T
    Keles S; Charbonnier LM; Kabaleeswaran V; Reisli I; Genel F; Gulez N; Al-Herz W; Ramesh N; Perez-Atayde A; Karaca NE; Kutukculer N; Wu H; Geha RS; Chatila TA
    J Allergy Clin Immunol; 2016 Nov; 138(5):1384-1394.e2. PubMed ID: 27350570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human hyper-IgE syndrome: singular or plural?
    Zhang Q; Boisson B; Béziat V; Puel A; Casanova JL
    Mamm Genome; 2018 Aug; 29(7-8):603-617. PubMed ID: 30094507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DOCK8 mutation diagnosed using whole-exome sequencing of the dried blood spot-derived DNA: a case report of an Iraqi girl diagnosed in Japan.
    Al-Kzayer LFY; Al-Aradi HMH; Shigemura T; Sano K; Tanaka M; Hamada M; Ali KH; Aldaghir OM; Nakazawa Y; Okuno Y
    BMC Med Genet; 2019 Jun; 20(1):114. PubMed ID: 31242861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical manifestations of hyper IgE syndromes.
    Freeman AF; Holland SM
    Dis Markers; 2010; 29(3-4):123-30. PubMed ID: 21178271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome.
    Engelhardt KR; McGhee S; Winkler S; Sassi A; Woellner C; Lopez-Herrera G; Chen A; Kim HS; Lloret MG; Schulze I; Ehl S; Thiel J; Pfeifer D; Veelken H; Niehues T; Siepermann K; Weinspach S; Reisli I; Keles S; Genel F; Kutukculer N; Camcioğlu Y; Somer A; Karakoc-Aydiner E; Barlan I; Gennery A; Metin A; Degerliyurt A; Pietrogrande MC; Yeganeh M; Baz Z; Al-Tamemi S; Klein C; Puck JM; Holland SM; McCabe ER; Grimbacher B; Chatila TA
    J Allergy Clin Immunol; 2009 Dec; 124(6):1289-302.e4. PubMed ID: 20004785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyper-IgE syndromes: recent advances in pathogenesis, diagnostics and clinical care.
    Farmand S; Sundin M
    Curr Opin Hematol; 2015 Jan; 22(1):12-22. PubMed ID: 25469836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyper IgE syndromes: A clinical approach.
    Gharehzadehshirazi A; Amini A; Rezaei N
    Clin Immunol; 2022 Apr; 237():108988. PubMed ID: 35351598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical Localization of Eczema Discriminates DOCK8 or STAT3 Deficiencies from Atopic Dermatitis.
    Kasap N; Kara A; Celik V; Bilgic Eltan S; Akay Haci I; Kose H; Aygun A; Akkelle E; Yakici N; Guner SN; Reisli I; Keles S; Cekic S; Kilic SS; Karaca NE; Gulez N; Genel F; Ozen A; Yucelten AD; Karakoc-Aydiner E; Schmitz-Abe K; Baris S
    J Clin Immunol; 2023 Nov; 43(8):1882-1890. PubMed ID: 37507632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autosomal recessive hyper-IgE syndrome caused by DOCK8 gene mutation with new clinical features: a case report.
    Yang J; Liu Y
    BMC Neurol; 2021 Jul; 21(1):288. PubMed ID: 34301197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ten-year follow-up of a DOCK8-deficient child with features of systemic lupus erythematosus.
    Jouhadi Z; Khadir K; Ailal F; Bouayad K; Nadifi S; Engelhardt KR; Grimbacher B
    Pediatrics; 2014 Nov; 134(5):e1458-63. PubMed ID: 25332498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A set of clinical and laboratory markers differentiates hyper-IgE syndrome from severe atopic dermatitis.
    Kasap N; Celik V; Isik S; Cennetoglu P; Kiykim A; Eltan SB; Nain E; Ogulur I; Baser D; Akkelle E; Celiksoy MH; Kocamis B; Cipe FE; Yucelten AD; Karakoc-Aydiner E; Ozen A; Baris S
    Clin Immunol; 2021 Feb; 223():108645. PubMed ID: 33301882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Manifestations and Genetic Analysis of 17 Patients with Autosomal Dominant Hyper-IgE Syndrome in Mainland China: New Reports and a Literature Review.
    Wu J; Chen J; Tian ZQ; Zhang H; Gong RL; Chen TX; Hong L
    J Clin Immunol; 2017 Feb; 37(2):166-179. PubMed ID: 28197791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous manifestations of DOCK8 deficiency syndrome.
    Chu EY; Freeman AF; Jing H; Cowen EW; Davis J; Su HC; Holland SM; Turner ML
    Arch Dermatol; 2012 Jan; 148(1):79-84. PubMed ID: 21931011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.